Inventor · disambiguated record
Christopher Andrew Bunka
Also filed as: BUNKA CHRISTOPHER ANDREW
13 granted patents·23 pending applications·37 citations·filing 2016–2025
88Inventor score
Top patents by PatentIndex Score
36 records- 0196US11666544B1Compositions and methods for treating hypertensionPOVIVA CORP·Filed 2022·Granted Jun 6, 2023·13 cites·18 claims
- 0296US11666543B1Pharmaceutical compositions and methods for treating hypertensionPOVIVA CORP·Filed 2022·Granted Jun 6, 2023·13 cites·16 claims
- 0395US11944635B1Compositions and methods for treating epilepsyPOVIVA CORP·Filed 2023·Granted Apr 2, 2024·4 cites·29 claims
- 0493US12220422B1Compositions and methods for treating epilepsyPOVIVA CORP·Filed 2024·Granted Feb 11, 2025·1 cites·30 claims
- 0593US12213986B1Compositions and methods for treating epilepsyPOVIVA CORP·Filed 2024·Granted Feb 4, 2025·1 cites·24 claims
- 0693US12023346B1Compositions and methods for treating epilepsyPOVIVA CORP·Filed 2023·Granted Jul 2, 2024·2 cites·13 claims
- 0791US11986485B1Compositions and methods for treating epilepsyPOVIVA CORP·Filed 2023·Granted May 21, 2024·1 cites·22 claims
- 0891US11931369B1Compositions and methods for treating epilepsyPOVIVA CORP·Filed 2023·Granted Mar 19, 2024·1 cites·12 claims
- 0988US12472236B2Compositions and methods for treating diabetesPOVIVA CORP·Filed 2024·Granted Nov 18, 2025·0 cites·18 claims
- 1088US12397042B2Compositions and methods for treating diabetesPOVIVA CORP·Filed 2024·Granted Aug 26, 2025·0 cites·11 claims
- 1186US11311559B2Compositions and methods for enhanced delivery of antiviral agentsPOVIVA CORP·Filed 2021·Granted Apr 26, 2022·1 cites·21 claims
- 1284US2024226033A1Compositions and methods for treating hypertensionPOVIVA CORP·Filed 2024·Application pending·0 cites
- 1383US2025352623A1Compositions and methods for treating diabetesPOVIVA CORP·Filed 2025·Application pending·0 cites
- 1473US11980593B2Compositions and methods for treating hypertensionPOVIVA CORP·Filed 2022·Granted May 14, 2024·0 cites·20 claims
- 1569US2021235716A1Stable ready-to-drink beverage compositions comprising lipophilic active agentsPOVIVA CORP·Filed 2021·Application pending·0 cites
- 1669US2025161333A1Compositions and methods for treating epilepsyPOVIVA CORP·Filed 2025·Application pending·0 cites
- 1766US11700875B1Compositions and methods for sublingual delivery of nicotinePOVIVA CORP·Filed 2022·Granted Jul 18, 2023·0 cites·30 claims
- 1866US2021177978A1Methods for formulating orally ingestible compositions comprising lipophilic active agentsPOVIVA CORP·Filed 2021·Application pending·0 cites
- 1964US2025032516A1Compositions and methods for treating epilepsyPOVIVA CORP·Filed 2023·Application pending·0 cites
- 2064US2025387416A1Compositions and methods for treating diabetesPOVIVA CORP·Filed 2024·Application pending·0 cites
- 2163US2023301341A1Compositions and methods for sublingual delivery of nicotinePOVIVA CORP·Filed 2022·Application pending·0 cites
- 2262US2020008442A1Stable ready-to-drink beverage compositions comprising lipophilic active agentsPOVIVA TEA LLC·Filed 2019·Application pending·0 cites
- 2360US2024009140A1Pharmaceutical compositions and methods for treating hypertensionPOVIVA CORP·Filed 2022·Application pending·0 cites
- 2458US2020178572A1Microwave processing methods for formulating orally ingestible compositions comprising lipophilic active agentsPOVIVA TEA LLC·Filed 2018·Application pending·0 cites
- 2558US2020061195A1Methods for formulating orally ingestible compositions comprising lipophilic active agentsPOVIVA TEA LLC·Filed 2019·Application pending·0 cites
- 2654US2021213091A1Lipophilic active agent infused tobacco leaves and/or tobacco materials and methods of use thereofPOVIVA CORP·Filed 2021·Application pending·0 cites
- 2754US2018116240A1Stable ready-to-drink beverage compositions comprising lipophilic active agentsPOVIVA TEA LLC·Filed 2016·Application pending·0 cites
- 2851US2021145036A1Lipophilic active agent infused compositions with reduced food effectPOVIVA TEA LLC·Filed 2019·Application pending·0 cites
- 2951US2023094827A1Nanoemulsion compositions comprising biologically active ingredientsPOVIVA CORP·Filed 2020·Application pending·0 cites
- 3051US2021145841A1Enhancement of delivery of lipophilic active agents across the blood-brain barrier and methods for treating central nervous system disordersPOVIVA CORP·Filed 2019·Application pending·0 cites
- 3151US2022160731A1Compositions comprising biologically active agents and bile saltsPOVIVA CORP·Filed 2020·Application pending·0 cites
- 3250US2018117161A1Methods for formulating orally ingestible compositions comprising lipophilic active agentsPOVIVA TEA LLC·Filed 2016·Application pending·0 cites
- 3350US2021045998A1Transdermal and/or dermal delivery of lipophilic active agentsPOVIVA CORP·Filed 2019·Application pending·0 cites
- 3450US2021289832A1Lipophilic active agent infused tobacco leaves and/or tobacco materials and methods of use thereofPOVIVA TEA LLC·Filed 2019·Application pending·0 cites
- 3549US2020323773A1Food and beverage compositions comprising pde5 inhibitorsPOVIVA CORP·Filed 2018·Application pending·0 cites
- 3648US2021145818A1Compositions infused with nicotine compounds and methods of use thereofPOVIVA TEA LLC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher Andrew Bunka files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →